Related Experiment Videos
Teratogenic effects of a chelating agent and their prevention by zinc
Insights
Ethylenediaminetetraacetic acid (EDTA) exposure during pregnancy caused birth defects in rats. Supplementing with zinc prevented these adverse reproductive outcomes, highlighting zinc's crucial role.
Area of Science:
- Reproductive toxicology
- Developmental biology
- Nutritional science
Background:
- Chelating agents can interfere with essential mineral absorption.
- Ethylenediaminetetraacetic acid (EDTA) is a known chelating agent.
- Pregnancy is a critical period for fetal development, sensitive to nutritional deficiencies.
Purpose of the Study:
- To investigate the effects of ethylenediaminetetraacetic acid (EDTA) exposure on reproduction and fetal development in rats.
- To determine if zinc supplementation can prevent EDTA-induced developmental abnormalities.
Main Methods:
- Female rats were administered ethylenediaminetetraacetic acid (EDTA) during gestation (days 6-21).
- Some groups received simultaneous supplementation with dietary zinc (1000 ppm).
- Offspring were examined for congenital malformations and reproductive outcomes.
Main Results:
- EDTA ingestion during pregnancy led to significant reproductive impairment.
- All full-term offspring from EDTA-exposed mothers exhibited gross congenital malformations.
- Concurrent zinc supplementation completely prevented the EDTA-induced malformations.
Conclusions:
- Ethylenediaminetetraacetic acid (EDTA) poses a risk to fetal development during pregnancy.
- Zinc is essential for preventing EDTA-induced teratogenicity.
- Dietary zinc supplementation can mitigate the adverse reproductive effects of EDTA exposure.
Abstract:
Ingestion of a chelating agent (ethylenediaminetetraacetic acid) by female rats during pregnancy impaired reproduction and resulted in congenitally malformed young. When ethylenediaminetetraacetic acid was fed from days 6 to 21 of gestation, all of the full-term young had gross congenital malformations. These effects were prevented by simultaneous supplementation with 1000 parts per million of dietary zinc.